327 related articles for article (PubMed ID: 28941937)
1. Exploiting homing abilities of cell carriers: Targeted delivery of nanoparticles for cancer therapy.
Tiet P; Berlin JM
Biochem Pharmacol; 2017 Dec; 145():18-26. PubMed ID: 28941937
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Nano-engineered mesenchymal stem cells as targeted therapeutic carriers.
Sadhukha T; O'Brien TD; Prabha S
J Control Release; 2014 Dec; 196():243-51. PubMed ID: 25456830
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
5. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
7. Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments.
de la Torre P; Pérez-Lorenzo MJ; Alcázar-Garrido Á; Flores AI
Molecules; 2020 Feb; 25(3):. PubMed ID: 32046010
[TBL] [Abstract][Full Text] [Related]
8. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
[TBL] [Abstract][Full Text] [Related]
9. [The development of novel tumor targeting delivery strategy].
Gao HL; Jiang XG
Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
[TBL] [Abstract][Full Text] [Related]
10. Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.
Yang Q; Parker CL; McCallen JD; Lai SK
J Control Release; 2015 Dec; 220(Pt B):715-26. PubMed ID: 26407672
[TBL] [Abstract][Full Text] [Related]
11. Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma?
Auffinger B; Morshed R; Tobias A; Cheng Y; Ahmed AU; Lesniak MS
Oncotarget; 2013 Mar; 4(3):378-96. PubMed ID: 23594406
[TBL] [Abstract][Full Text] [Related]
12. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
Acharya S; Sahoo SK
Adv Drug Deliv Rev; 2011 Mar; 63(3):170-83. PubMed ID: 20965219
[TBL] [Abstract][Full Text] [Related]
13. Albumin-Gold Nanorod Nanoplatform for Cell-Mediated Tumoritropic Delivery with Homogenous ChemoDrug Distribution and Enhanced Retention Ability.
Chiu HT; Su CK; Sun YC; Chiang CS; Huang YF
Theranostics; 2017; 7(12):3034-3052. PubMed ID: 28839462
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in mesoporous silica nanoparticles for antitumor therapy: our contribution.
Baeza A; Manzano M; Colilla M; Vallet-Regí M
Biomater Sci; 2016 May; 4(5):803-13. PubMed ID: 26902682
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle approaches to combating drug resistance.
Moon JH; Moxley JW; Zhang P; Cui H
Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
[TBL] [Abstract][Full Text] [Related]
16. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
[TBL] [Abstract][Full Text] [Related]
17. Self-Monitoring and Self-Delivery of Photosensitizer-Doped Nanoparticles for Highly Effective Combination Cancer Therapy in Vitro and in Vivo.
Zhang J; Liang YC; Lin X; Zhu X; Yan L; Li S; Yang X; Zhu G; Rogach AL; Yu PK; Shi P; Tu LC; Chang CC; Zhang X; Chen X; Zhang W; Lee CS
ACS Nano; 2015 Oct; 9(10):9741-56. PubMed ID: 26390118
[TBL] [Abstract][Full Text] [Related]
18. Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor.
Li X; Wu M; Pan L; Shi J
Int J Nanomedicine; 2016; 11():93-105. PubMed ID: 26766908
[TBL] [Abstract][Full Text] [Related]
19. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
Kamath PR; Sunil D
Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
[TBL] [Abstract][Full Text] [Related]
20. Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy.
Si J; Shao S; Shen Y; Wang K
Small; 2016 Oct; 12(37):5108-5119. PubMed ID: 27560388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
